ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Claude Deschamps
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawyer, T. E.
Right arrow Articles by Li, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawyer, T. E.
Right arrow Articles by Li, H.

Ann Thorac Surg 1999;68:1171-1176
© 1999 The Society of Thoracic Surgeons

Original Articles

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma

Timothy E. Sawyer, MDa, James A. Bonner, MDa, Perry M. Gould, MDa, Robert L. Foote, MDa, Claude Deschamps, MDa, Carla M. Lange, BSa, Hongzhe Li, PhDa

a Divisions of Radiation Oncology, Thoracic and Cardiovascular Surgery, and the Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

Address reprint requests to Dr Bonner, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

Background. Although irradiation and chemotherapy are unproved adjuvant treatments for completely resected N1 non–small cell lung carcinoma, previous studies may have been diluted by the inclusion of low-risk patients. Risk factors in this situation, however, are not yet well defined.

Methods. One hundred seven consecutive patients with complete resection of N1 disease who received no other therapy were studied to identify factors independently predicting the risk of freedom from local recurrence (FFLR), freedom from distant metastasis (FFDM), and overall survival (OS).

Results. Twelve factors were assessed for a potential prognostic relationship with FFLR, FFDM, and OS. Regression analyses revealed that the factors independently associated with an improved outcome were positive bronchoscopic findings (FFLR, p = 0.005), a greater number of dissected N1 nodes (FFDM, p = 0.02), and a lesser T stage (OS, p = 0.01). Classification and regression tree analyses were then used to separate the patients into risk groups.

Conclusions. Although these results require corroboration in further studies, they may aid the design of trials examining therapies used to decrease rates of local recurrence or distant metastasis.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. Demir, A. Turna, C. Kocaturk, M. Z. Gunluoglu, U. Aydogmus, N. Urer, M. A. Bedirhan, A. Gurses, and S. I. Dincer
Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non-Small Cell Lung Cancer
Ann. Thorac. Surg., April 1, 2009; 87(4): 1014 - 1022.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. H. Kang, Y. J. Ra, Y. T. Kim, S.-H. Jheon, S.-w. Sung, and J. H. Kim
The Impact of Multiple Metastatic Nodal Stations on Survival in Patients With Resectable N1 and N2 Nonsmall-Cell Lung Cancer
Ann. Thorac. Surg., October 1, 2008; 86(4): 1092 - 1097.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
N. K. Veeramachaneni, R. J. Battafarano, B. F. Meyers, J. B. Zoole, and G. A. Patterson
Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 466 - 469.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Fujimoto, S. D. Cassivi, P. Yang, S. A. Barnes, F. C. Nichols, C. Deschamps, M. S. Allen, and P. C. Pairolero
Completely resected N1 non-small cell lung cancer: Factors affecting recurrence and long-term survival.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 499 - 506.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Bonner and S. A. Spencer
Postoperative Radiotherapy in Non--Small-Cell Lung Cancer Warrants Further Exploration in the Era of Adjuvant Chemotherapy and Conformal Radiotherapy
J. Clin. Oncol., July 1, 2006; 24(19): 2978 - 2980.
[Full Text] [PDF]

Home page
 ChestHome page
M. S. Ludwig, M. Goodman, D. L. Miller, and P. A. S. Johnstone
Postoperative Survival and the Number of Lymph Nodes Sampled During Resection of Node-Negative Non-Small Cell Lung Cancer
Chest, September 1, 2005; 128(3): 1545 - 1550.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Marra, L. Hillejan, G. Zaboura, T. Fujimoto, D. Greschuchna, and G. Stamatis
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 543 - 553.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Bonner, S. A. Tincher, and J. B. Fiveash
Balancing the Possible Effectiveness of Postoperative Radiotherapy for Non-Small-Cell Lung Cancer Against the Possible Detriment of Radiation-Induced Toxicity
J. Clin. Oncol., October 1, 2001; 19(19): 3905 - 3907.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
H. Asamura, K. Suzuki, H. Kondo, and R. Tsuchiya
Where is the boundary between N1 and N2 stations in lung cancer?
Ann. Thorac. Surg., December 1, 2000; 70(6): 1839 - 1846.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.